Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2020-09-30 Foreign Filer Report
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2020-09-30 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 100% confidence The document is titled 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons'. It explicitly references Article 19 of Regulation No. 596/2014 on Market Abuse, which is the standard regulatory framework for reporting insider/director dealings. The document serves as a disclosure of these specific transactions. While it includes an attachment link, the text itself is the primary disclosure of the trading activity, fitting the 'Director's Dealing' category.
2020-09-30 English
Director's Dealing 2020
Director's Dealing Classification · 100% confidence The document is titled "Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons" and explicitly references compliance with Article 19 of Regulation No. 596/2014 on Market Abuse. It details a specific sale of shares by a member of the Board of Directors (Anders Gersel Pedersen). This type of mandatory disclosure regarding insider trading or transactions by managerial personnel is specifically categorized as Director's Dealing (DIRS). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), but a specific report on insider transactions.
2020-09-30 English
6-K
Foreign Filer Report
2020-09-30 English
6-K
Foreign Filer Report
2020-09-29 English
6-K
Foreign Filer Report
2020-09-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.